4.950USD-3.88%Mkt Cap: 383.97M USDP/E: —Last update: 2026-06-01
Lexeo Therapeutics, Inc., a clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States. Its product pipeline comprises LX2006, an AAVrh10-based gene the…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap383.97M USD
Enterprise Value217.92M USD
Revenue (TTM)—
Gross Profit-62.33M USD
Net Income (TTM)-99.96M USD
Revenue/Share—
Last Price4.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees59
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.20
PEG—
EV/EBITDA-2.24
EV/Revenue—
P/S—
P/B1.64
EPS (TTM)-1.12
EPS (Forward)-1.22
52W Range
2.67027% of range10.99
52W High10.99 USD
52W Low2.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-40.52%
ROA-37.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-98.56M USD
CapEx (TTM)397.00K USD
FCF Margin—
FCF Yield-17.54%
Net Debt-185.68M USD
Net Debt/EBITDA1.91
Balance Sheet
Debt/Equity0.03
Current Ratio14.16
Quick Ratio13.61
Book Value/Sh3.125 USD
Cash/Share2.458 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)20.60 USD
Target Range12.00 USD – 30.00 USD
# Analysts10
Ownership
Shares Out.78.52M
Float47.53M
Insiders0.55%
Institutions115.53%
Short Interest
Short Ratio18.8d
Short % Float19.78%
Short % Out.16.83%
Shares Short13.21M
Short (prev mo.)12.60M
Technical
SMA 505.782 (-14.4%)
SMA 2007.162 (-30.9%)
Beta1.53
S&P 52W Chg27.94%
Avg Vol (30d)703.31K
Avg Vol (10d)775.03K
Technical Indicators
RSI (14)43.0
MACD-0.2563
MACD Signal-0.2580
MACD Hist.+0.0016
BB Upper6.387 USD
BB Middle5.438 USD
BB Lower4.488 USD
BB Width34.91%
ATR (14)0.3705 USD
Vol Ratio (20d)0.47x